Antinozzi P A, Segall L, Prentki M, McGarry J D, Newgard C B
Departments of Biochemistry & Internal Medicine and Gifford Laboratories for Diabetes Research, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA.
J Biol Chem. 1998 Jun 26;273(26):16146-54. doi: 10.1074/jbc.273.26.16146.
The mechanism by which glucose stimulates insulin secretion from the pancreatic islets of Langerhans is incompletely understood. It has been suggested that malonyl-CoA plays a regulatory role by inhibiting fatty acid oxidation and promoting accumulation of cytosolic long-chain acyl-CoA (LC-CoA). In the current study, we have re-evaluated this "long-chain acyl-CoA hypothesis" by using molecular and pharmacologic methods to perturb lipid metabolism in INS-1 insulinoma cells or rat islets during glucose stimulation. First, we constructed a recombinant adenovirus containing the cDNA encoding malonyl-CoA decarboxylase (AdCMV-MCD), an enzyme that decarboxylates malonyl-CoA to acetyl-CoA. INS-1 cells treated with AdCMV-MCD had dramatically lowered intracellular malonyl CoA levels compared with AdCMV-betaGal-treated cells at both 3 and 20 mM glucose. Further, at 20 mM glucose, AdCMV-MCD-treated cells were less effective at suppressing [1-14C]palmitate oxidation and incorporated 43% less labeled palmitate and 50% less labeled glucose into cellular lipids than either AdCMV-betaGAL-treated or untreated INS-1 cells. Despite the large metabolic changes caused by expression of MCD, insulin secretion in response to glucose was unaltered relative to controls. The alternative, pharmacologic approach for perturbing lipid metabolism was to use triacsin C to inhibit long-chain acyl-CoA synthetase. This agent caused potent attenuation of palmitate oxidation and glucose or palmitate incorporation into cellular lipids and also caused a 47% decrease in total LC-CoA. Despite this, the drug had no effect on glucose-stimulated insulin secretion in islets or INS-1 cells. We conclude that significant disruption of the link between glucose and lipid metabolism does not impair glucose-stimulated insulin secretion in pancreatic islets or INS-1 cells.
葡萄糖刺激胰岛β细胞分泌胰岛素的机制尚未完全明确。有研究表明,丙二酰辅酶A通过抑制脂肪酸氧化和促进细胞溶质长链酰基辅酶A(LC-CoA)的积累发挥调节作用。在本研究中,我们使用分子和药理学方法干扰葡萄糖刺激期间INS-1胰岛素瘤细胞或大鼠胰岛中的脂质代谢,重新评估了这一“长链酰基辅酶A假说”。首先,我们构建了一种重组腺病毒,其包含编码丙二酰辅酶A脱羧酶(AdCMV-MCD)的cDNA,该酶可将丙二酰辅酶A脱羧为乙酰辅酶A。在3 mM和20 mM葡萄糖条件下,与AdCMV-βGal处理的细胞相比,用AdCMV-MCD处理的INS-1细胞的细胞内丙二酰辅酶A水平显著降低。此外,在20 mM葡萄糖条件下,与AdCMV-βGal处理或未处理的INS-1细胞相比,AdCMV-MCD处理的细胞抑制[1-14C]棕榈酸氧化的效果较差,并且掺入细胞脂质中的标记棕榈酸减少43%,标记葡萄糖减少50%。尽管MCD表达引起了巨大的代谢变化,但相对于对照组,葡萄糖刺激引起的胰岛素分泌并未改变。另一种干扰脂质代谢的药理学方法是使用三辛环素C抑制长链酰基辅酶A合成酶。该药物可有效减弱棕榈酸氧化以及葡萄糖或棕榈酸掺入细胞脂质的过程,还可使总LC-CoA降低47%。尽管如此,该药物对胰岛或INS-1细胞中葡萄糖刺激的胰岛素分泌没有影响。我们得出结论,葡萄糖与脂质代谢之间的联系受到显著破坏并不会损害胰岛或INS-1细胞中葡萄糖刺激的胰岛素分泌。